1 month ago
Thyrocare Technologies Q3 Results | EBITDA surged 32.4%, while the EBITDA margin stood at 25.1% versus 23.4% in the year-ago quarter. Shares of Thyrocare Technologies Ltd ended at ₹787.80, down by ₹10.25, or 1.28%, on the BSE.
Diagnostics firm Thyrocare Technologies Ltd on Monday (February 3) reported a 24% year-on-year (YoY) increase in net profit at ₹19.1 crore for the third quarter that ended December 31, 2024, compared to ₹15.4 crore in the same period in FY24.
Revenue from operations was up 23.2% to ₹165.9 crore against ₹134.7 crore in the corresponding period of the preceding fiscal.
Also Read: Gateway Distriparks Q3 Results | Net profit rockets 7-fold to ₹456 crore, declares dividend
At the operating level, EBITDA surged 32.4% to ₹41.7 crore in the third quarter of this fiscal over ₹31.5 crore YoY.
The EBITDA margin stood at 25.1% in the reporting quarter versus 23.4% in the year-ago quarter. EBITDA is earnings before interest, tax, depreciation, and amortisation.
The results came after the close of the market hours. Shares of Thyrocare Technologies Ltd ended at ₹787.80, down by ₹10.25, or 1.28%, on the BSE.
Also Read: Alembic Pharma Q3 Results | Net profit declines 23% to ₹138 crore, net sales up 4%
(Edited by : Shoma Bhattacharjee)
